Emory University Ascendis Pharma A/S Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $1.76 Million - $2.18 Million	-18,334 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $1.51 Million - $1.87 Million	-14,143 Reduced 43.55%	18,334 $2.11 Million
Q1 2019 May 09, 2019	SELL	$62.15 - $129.99 $418,891 - $876,132	-6,740 Reduced 17.19%	32,477 $3.82 Million
Q4 2018 Feb 12, 2019	BUY	$55.16 - $69.67 $2.16 Million - $2.73 Million	39,217 New	39,217 $2.46 Million

223

56.5M

142K

259K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.97B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.